Anahita Aghaei Lasboo, MD
Neurology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lasboo’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A128727 · Current
Licensed to practise in California · since 2014 · expires 2028-02-29 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$27,443
Pharmacies billed $27,443 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 505) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
489 generic and fewer than 11 brand-name prescriptions · $27,443 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa | 132 | $7,105 | $54 |
| Levetiracetam | 71 | $3,327 | $47 |
| Gabapentin | 97 | $1,807 | $19 |
| Propranolol | 18 | $1,279 | $71 |
| Lamotrigine | 20 | $625 | $31 |
See all 7 drugs
| Carbidopa-Levodopa | 132 | $7,105 | $54 |
| Levetiracetam | 71 | $3,327 | $47 |
| Gabapentin | 97 | $1,807 | $19 |
| Propranolol | 18 | $1,279 | $71 |
| Lamotrigine | 20 | $625 | $31 |
| Divalproex | 12 | $452 | $38 |
| Pregabalin | 12 | $353 | $29 |
Year by year
| 2024 | 505 | 171 | 0% (0) | None | $27,443 |
| 2023 | 488 | 147 | None | 2% | $24,815 |
| 2022 | 434 | 134 | 0% (0) | None | $31,278 |
| 2021 | 293 | 93 | 0% (0) | 6% | $36,065 |
| 2020 | 274 | 78 | 0% (0) | 7% | $69,848 |
| 2019 | 486 | 130 | 0% (0) | None | $133,212 |
| 2018 | 300 | 114 | 0% (0) | None | $36,863 |
| 2017 | 207 | 69 | 0% (0) | 8% | $19,477 |
| 2016 | 16 | None | 0% (0) | None | $3,861 |
| 2015 | 18 | None | None | None | $3,419 |
| 2014 | 71 | 11 | 0% (0) | None | $13,629 |
| 2013 | 106 | 18 | None | 11% | $33,699 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Carbidopa-Levodopa | 112 | $6,462 | $58 |
| Levetiracetam | 76 | $3,338 | $44 |
| Gabapentin | 91 | $1,593 | $18 |
| Propranolol | 23 | $1,126 | $49 |
| Divalproex | 11 | $877 | $80 |
| Lamotrigine | 26 | $786 | $30 |
| Pramipexole Dihydrochloride | 11 | $180 | $16 |
2022: 6 drugs
| Carbidopa-Levodopa | 91 | $9,487 | $104 |
| Levetiracetam | 54 | $2,710 | $50 |
| Gabapentin | 106 | $1,650 | $16 |
| Propranolol | 18 | $1,299 | $72 |
| Lamotrigine | 25 | $537 | $21 |
| Divalproex | 12 | $495 | $41 |
2021: 5 drugs
| Carbidopa-Levodopa | 51 | $2,896 | $57 |
| Levetiracetam | 29 | $2,217 | $76 |
| Gabapentin | 62 | $1,231 | $20 |
| Divalproex | 11 | $575 | $52 |
| Lamotrigine | 20 | $360 | $18 |
2020: 4 drugs
| Levetiracetam | 19 | $1,952 | $103 |
| Carbidopa-Levodopa | 44 | $1,943 | $44 |
| Gabapentin | 73 | $1,423 | $19 |
| Lamotrigine | 14 | $164 | $12 |
2019: 13 drugs
| Gilenya | 11 | $94,462 | $8,587 |
| Gabapentin | 151 | $2,453 | $16 |
| Carbidopa-Levodopa | 41 | $1,197 | $29 |
| Carbamazepine | 12 | $1,077 | $90 |
| Memantine | 22 | $1,045 | $47 |
| Levetiracetam | 23 | $890 | $39 |
| Lamotrigine | 29 | $689 | $24 |
| Divalproex | 11 | $636 | $58 |
| Duloxetine | 13 | $420 | $32 |
| Propranolol | 16 | $371 | $23 |
| Atorvastatin | 14 | $228 | $16 |
| Donepezil | 20 | $219 | $11 |
| Quetiapine | 15 | $130 | $9 |
2018: 8 drugs
| Carbidopa-Levodopa | 61 | $3,487 | $57 |
| Gabapentin | 56 | $1,532 | $27 |
| Levetiracetam | 29 | $1,237 | $43 |
| Propranolol | 14 | $629 | $45 |
| Lamotrigine | 16 | $502 | $31 |
| Atorvastatin | 14 | $397 | $28 |
| Nortriptyline | 15 | $235 | $16 |
| Lorazepam | 13 | $46 | $4 |
2017: 3 drugs
| Gabapentin | 78 | $2,230 | $29 |
| Carbidopa-Levodopa | 26 | $2,030 | $78 |
| Levetiracetam | 35 | $1,519 | $43 |
2014: 1 drug
| Mycophenolate Mofetil | 11 | $1,415 | $129 |
2013: 6 drugs
| Mycophenolate Mofetil | 11 | $1,571 | $143 |
| Gabapentin | 11 | $1,063 | $97 |
| Baclofen | 15 | $205 | $14 |
| Levetiracetam | 12 | $184 | $15 |
| Clonazepam | 13 | $103 | $8 |
| Prednisone | 13 | $60 | $5 |
Money from drug and device companies
$1,430 in 2022
| 2022 | 1 | 5 | None | $1,430 |
| 2019 | 4 | 5 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LivaNova USA | Vns Therapy | $1,430 | 5 payments
|
See all 5 published payments
| LivaNova USA | Meals · 2022-10-24 | Vns Therapy | $11 |
| LivaNova USA | Travel · 2022-10-24 | Vns Therapy | $116 |
| LivaNova USA | Travel · 2022-10-21 | Vns Therapy | $225 |
| LivaNova USA | Travel · 2022-10-21 | Vns Therapy | $676 |
| LivaNova USA | Meals · 2022-10-21 | Vns Therapy | $401 |
See earlier years (2019)
2019: $113
| Novartis Pharmaceuticals | Mayzent | $39 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $29 | 1 payment
|
| Amgen | Aimovig | $27 | 1 payment
|
| Vertical Pharmaceuticals | Osmolex Er | $18 | 1 payment
|
Professional record
- NPI
- 1841503968
- Licence
- CA A128727California A128727: Current · expires 2028-02-29
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 710 Lawrence Expy Ste 460, Santa Clara, CA, 95051
- NPI first listed
- 2010-07-18
- NPI last updated
- 2023-04-04
- NPI record certified
- 2023-04-04
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.